13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$696.38B
−3.0% on the quarter before
Positions
6,729
633 new · 590 sold out
Top 10
17.3%
of the value
Est. gain
−$32.23B
on stocks held all quarter
Est. return
−5.0%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$3.41BAdded · 0.3% → 0.7%+9,549,700 underlying
- Vanguard Total Bond Market~$1.86BAdded · 0.6% → 0.9%+26,134,058 shares
- SPDR S&P 500 ETF TrCALL~$1.75BAdded · 0.1% → 0.4%+4,888,500 underlying
- Invesco Qqq Trust Series 1~$1.75BAdded · 0.1% → 0.4%+6,532,499 shares
- Vanguard Intermediate-Term Treasury Index Fund~$1.55BAdded · 0.0% → 0.3%+26,601,698 shares
- TeslaPUT~$1.38BAdded · 0.3% → 0.3%+5,212,300 underlying
- Invesco Qqq TrPUT~$1.07BAdded · 0.5% → 0.6%+3,989,400 underlying
- Unitedhealth Group Inc~$1.06BAdded · 1.4% → 1.6%+2,089,896 shares
- Ishares 7-10 Year Treasury B~$1.02BAdded · 0.4% → 0.5%+10,620,545 shares
- Ishares TrPUT~$966.6MAdded · 0.2% → 0.3%+13,540,400 underlying
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jpmorgan Betabuilders Europe ETF~$1.11BCut · 0.6% → 0.4%−27,548,823 shares
- Centene Corp Del~$720.1MCut · 0.4% → 0.2%−9,254,103 shares
- Amazon~$706.7MCut · 1.6% → 1.6%−6,254,171 shares
- Ishares TrPUT~$686.3MSold out · 0.1% → 0.0%−6,024,900 underlying
- Texas Instruments~$660.4MCut · 0.5% → 0.5%−4,266,852 shares
- SPDR Gold TrPUT~$524.2MCut · 0.4% → 0.3%−3,389,200 underlying
- Ishares Msci Eafe ETF~$511.3MCut · 0.4% → 0.3%−9,128,026 shares
- Chevron Corp New~$507.5MCut · 0.4% → 0.3%−3,532,556 shares
- Analog Devices~$446.5MCut · 0.5% → 0.4%−3,204,298 shares
- Vanguard Long-Term Treasury ETF~$444.5MCut · 0.1% → 0.0%−7,062,301 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON · shares +1.9% · price −9.3% | 3.1% | $21.60B | −$2.18B | ||||||||
| SPDR S&P 500 ETF TrustFUND · shares −1.4% · price −5.3% | 2.9% | $20.36B | −$1.14B | ||||||||
| AppleCOMMON · shares −2.4% · price +1.1% | 2.5% | $17.08B | +$183.0M | ||||||||
| AmazonCOMMON · shares −5.9% · price +6.4% | 1.6% | $11.36B | +$682.5M | ||||||||
| Unitedhealth Group IncCOMMON · shares +10% · price −1.7% | 1.6% | $11.28B | −$174.0M | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +8.9% · price −3.7% | 1.4% | $10.04B | −$349.7M | ||||||||
| Abbvie IncCOMMON · shares +4.2% · price −12.4% | 1.1% | $7.85B | −$1.06B | ||||||||
| AlphabetCOMMON · shares +1.8% · price −16.5% | 1.1% | $7.46B | −$1.45B | ||||||||
| Bristol-Myers Squibb CoCOMMON · shares +1.8% · price −7.7% | 1.0% | $7.07B | −$577.8M | ||||||||
| TeslaCOMMON · shares +7.7% · price +18.2% | 0.95% | $6.61B | +$943.6M | ||||||||
| AlphabetCOMMON · shares +0.2% · price −12.2% | 0.91% | $6.30B | −$875.7M | ||||||||
| Vanguard Total Bond MarketFUND · shares +43% · price −5.2% | 0.90% | $6.25B | −$241.5M | ||||||||
| ConocophillipsCOMMON · shares −1.7% · price +14.0% | 0.79% | $5.50B | +$673.4M | ||||||||
| SPDR S&P 500 ETF TrPUTOPTION · shares +189% | 0.75% | $5.21B | — | ||||||||
| Johnson & JohnsonCOMMON · shares −0.9% · price −8.0% | 0.71% | $4.92B | −$426.4M | ||||||||
| Nextera Energy IncCOMMON · shares −2.8% · price +1.2% | 0.71% | $4.92B | +$59.6M | ||||||||
| Jpmorgan Betabuilders Japan ETFFUND · shares +1.0% · price −7.4% | 0.70% | $4.85B | −$381.2M | ||||||||
| Eli LillyCOMMON · shares −4.8% · price −0.3% | 0.69% | $4.77B | −$13.0M | ||||||||
| MastercardCOMMON · shares −1.6% · price −9.9% | 0.68% | $4.74B | −$519.2M | ||||||||
| Coca Cola CoCOMMON · shares +0.3% · price −11.0% | 0.64% | $4.43B | −$543.7M | ||||||||
| Invesco Qqq TrPUTOPTION · shares +32% | 0.63% | $4.37B | — | ||||||||
| Exxon Mobil CorpCOMMON · shares +23% · price +2.0% | 0.62% | $4.35B | +$67.8M | ||||||||
| Deere & CoCOMMON · shares −6.8% · price +11.5% | 0.62% | $4.33B | +$446.4M | ||||||||
| Mcdonalds CorpCOMMON · shares −4.6% · price −6.5% | 0.62% | $4.32B | −$302.2M | ||||||||
| Jpmorgan Betabuilders CanadaFUND · shares −0.4% · price −9.0% | 0.61% | $4.25B | −$420.5M | ||||||||
| Total · 6,729 positions | 100% | $696.38B | −$32.23B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 4,802 stocks held throughout, down $32.23B (−5.0%).
- Tesla3:1 split+$943.6M+18%
- Amazon+$682.5M+6%
- Conocophillips+$673.4M+14%
- Regeneron Pharmaceuticals+$555.0M+17%
- Deere & Co+$446.4M+11%
- Alphabet20:1 split−$875.7M−12%
- Abbvie Inc−$1.06B−12%
- SPDR S&P 500 ETF Trust−$1.14B−5%
- Alphabet19:1 split−$1.45B−16%
- Microsoft−$2.18B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 22 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |